MBAL:CA:TSX-Mackenzie Balanced Allocation ETF (CAD)

ETF | Others |

Last Closing

CAD 25.77

Change

0.00 (0.00)%

Market Cap

CAD 0.12B

Volume

150.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+0.10 (+0.29%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

-0.21 (-0.67%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

-0.12 (-0.47%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.19 (+0.51%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

-0.01 (-0.02%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.61 (+1.22%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.74 (+2.55%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.05 (+0.43%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

+0.04 (+0.18%)

CAD 2.78B

ETFs Containing MBAL:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.74% 70% C- 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.74% 68% D+ 53% F
Trailing 12 Months  
Capital Gain 10.13% 67% D+ 62% D
Dividend Return 2.07% 55% F 39% F
Total Return 12.20% 70% C- 61% D-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.50% 53% F 48% F
Dividend Return 4.05% 51% F 42% F
Total Return 0.55% 58% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 9.52% 51% F 74% C
Risk Adjusted Return 42.56% 48% F 54% F
Market Capitalization 0.12B 66% D+ 37% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.